We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
(-25%)
Cap. Flow
-$5.59B
Cap. Flow
% of AUM
-19.76%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$97.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$95.6M |
| 3 |
Cheniere Energy
LNG
|
+$94.4M |
| 4 |
Visa
V
|
+$92.5M |
| 5 |
AstraZeneca
AZN
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$204M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
NVIDIA
NVDA
|
+$131M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$130M |
| 5 |
Marathon Petroleum
MPC
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 13.09% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Intercorp Financial Services
IFS
$6.29B
| $3.46M | 0.01% |
+147,658
| New | +$4.07M |
|
452
SI-BONE Inc
SIBN
$818M
| $3.27M | 0.01% |
247,346
+16,952
| +7% | +$282K |
|
453
Warner Music
WMG
$15.2B
| $3.23M | 0.01% |
132,587
+20,458
| +18% | +$611K |
|
454
Beam Therapeutics
BEAM
$2.68B
| $3.11M | 0.01% |
80,294
+15,725
| +24% | +$625K |
|
455
Procept Biorobotics
PRCT
$1.02B
| $3.02M | 0.01% |
+92,260
| New | +$3.36M |
|
456
Century Aluminum
CENX
$4.22B
| $2.65M | 0.01% |
359,098
-121,687
| -25% | -$1.89M |
|
457
Pulmonx
LUNG
$52.8M
| $2.64M | 0.01% |
179,354
+12,078
| +7% | +$249K |
|
|
EWCZ
458
DELISTED
European Wax Center
EWCZ
| $2.58M | 0.01% |
146,296
-57,391
| -28% | -$1.46M |
|
459
BILL Holdings
BILL
$4.72B
| $2.56M | 0.01% |
23,332
-11,967
| -34% | -$1.74M |
|
460
Warby Parker
WRBY
$3.19B
| $2.56M | 0.01% |
227,545
-65,368
| -22% | -$1.31M |
|
461
Pliant Therapeutics
PLRX
$65M
| $2.55M | 0.01% |
318,759
+21,725
| +7% | +$139K |
|
|
UDMY
462
DELISTED
Udemy
UDMY
| $2.47M | 0.01% |
+242,117
| New | +$2.93M |
|
463
Riskified
RSKD
$719M
| $2.36M | 0.01% |
531,384
+146,377
| +38% | +$758K |
|
464
Outfront Media
OUT
$5.75B
| $2.32M | 0.01% |
138,952
-15,443
| -10% | -$336K |
|
465
Turning Point Brands
TPB
$1.48B
| $2.27M | 0.01% |
83,571
-9,300
| -10% | -$273K |
|
466
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $2.23M | 0.01% |
15,961
-1,002
| -6% | -$147K |
|
467
iHeartMedia
IHRT
$531M
| $2.05M | 0.01% |
259,995
-657
| -0.3% | -$8.86K |
|
|
XM
468
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $1.93M | 0.01% |
154,455
-2,797,664
| -95% | -$49.8M |
|
469
Credicorp
BAP
$30.5B
| $1.8M | 0.01% |
+15,045
| New | +$2.07M |
|
|
NGM
470
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.7M | 0.01% |
132,426
-800
| -0.6% | -$11.1K |
|
471
Snap
SNAP
$7.96B
| $1.67M | 0.01% |
127,511
+38,157
| +43% | +$870K |
|
472
Western Alliance Bancorporation
WAL
$8.81B
| $1.45M | 0.01% |
20,473
-776,087
| -97% | -$59.4M |
|
|
ALTR
473
DELISTED
Altair Engineering Inc
ALTR
| $1.41M | 0.01% |
26,786
| – | – |
|
474
Fidelity National Information Services
FIS
$24.2B
| $1.39M | ﹤0.01% |
+15,202
| New | +$1.51M |
|
|
LUXE
475
LuxExperience B.V.
LUXE
$1.13B
| $1.31M | ﹤0.01% |
132,293
-164,225
| -55% | -$1.86M |
|
Similar funds
Lord, Abbett & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.
- Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
- Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
- Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
- Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
- Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
- Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.
Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.